BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 22783993)

  • 1. From prediction to experimental validation: desmoglein 2 is a functionally relevant substrate of matriptase in epithelial cells and their reciprocal relationship is important for cell adhesion.
    Wadhawan V; Kolhe YA; Sangith N; Gautam AK; Venkatraman P
    Biochem J; 2012 Oct; 447(1):61-70. PubMed ID: 22783993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteolytic processing of the serine protease matriptase-2: identification of the cleavage sites required for its autocatalytic release from the cell surface.
    Stirnberg M; Maurer E; Horstmeyer A; Kolp S; Frank S; Bald T; Arenz K; Janzer A; Prager K; Wunderlich P; Walter J; Gütschow M
    Biochem J; 2010 Aug; 430(1):87-95. PubMed ID: 20518742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of matriptase-2 on prostate cancer in vitro: a possible role for β-catenin.
    Webb SL; Sanders AJ; Mason MD; Jiang WG
    Oncol Rep; 2012 Oct; 28(4):1491-7. PubMed ID: 22858929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of a membrane-bound serine protease matriptase on the cell surface.
    Miyake Y; Yasumoto M; Tsuzuki S; Fushiki T; Inouye K
    J Biochem; 2009 Aug; 146(2):273-82. PubMed ID: 19398443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-localization of the channel activating protease prostasin/(CAP1/PRSS8) with its candidate activator, matriptase.
    List K; Hobson JP; Molinolo A; Bugge TH
    J Cell Physiol; 2007 Oct; 213(1):237-45. PubMed ID: 17471493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel substrate-binding pocket interaction restricts the specificity of the human NK cell-specific serine protease, Met-ase-1.
    Smyth MJ; O'Connor MD; Trapani JA; Kershaw MH; Brinkworth RI
    J Immunol; 1996 Jun; 156(11):4174-81. PubMed ID: 8666785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights into matriptase-2 substrate binding and inhibition mechanisms by analyzing active-site-mutated variants.
    Maurer E; Sisay MT; Stirnberg M; Steinmetzer T; Bajorath J; Gütschow M
    ChemMedChem; 2012 Jan; 7(1):68-72. PubMed ID: 21919209
    [No Abstract]   [Full Text] [Related]  

  • 8. A recombinant catalytic domain of matriptase induces detachment and apoptosis of small-intestinal epithelial IEC-6 cells cultured on laminin-coated surface.
    Mochida S; Tsuzuki S; Inouye K; Fushiki T
    J Biochem; 2010 Dec; 148(6):721-32. PubMed ID: 20855298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strong expression association between matriptase and its substrate prostasin in breast cancer.
    Bergum C; Zoratti G; Boerner J; List K
    J Cell Physiol; 2012 Apr; 227(4):1604-9. PubMed ID: 21678412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of membrane-bound serine proteinase matriptase as processing enzyme of insulin-like growth factor binding protein-related protein-1 (IGFBP-rP1/angiomodulin/mac25).
    Ahmed S; Jin X; Yagi M; Yasuda C; Sato Y; Higashi S; Lin CY; Dickson RB; Miyazaki K
    FEBS J; 2006 Feb; 273(3):615-27. PubMed ID: 16420484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent and specific inhibition of the biological activity of the type-II transmembrane serine protease matriptase by the cyclic microprotein MCoTI-II.
    Gray K; Elghadban S; Thongyoo P; Owen KA; Szabo R; Bugge TH; Tate EW; Leatherbarrow RJ; Ellis V
    Thromb Haemost; 2014 Aug; 112(2):402-11. PubMed ID: 24696092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the stem domain of matriptase in the interaction with its physiological inhibitor, hepatocyte growth factor activator inhibitor type I.
    Kojima K; Tsuzuki S; Fushiki T; Inouye K
    J Biochem; 2009 Jun; 145(6):783-90. PubMed ID: 19276202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intramembrane proteolysis of Mgm1 by the mitochondrial rhomboid protease is highly promiscuous regarding the sequence of the cleaved hydrophobic segment.
    Schäfer A; Zick M; Kief J; Steger M; Heide H; Duvezin-Caubet S; Neupert W; Reichert AS
    J Mol Biol; 2010 Aug; 401(2):182-93. PubMed ID: 20558178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactive matriptase-2 mutants found in IRIDA patients still repress hepcidin in a transfection assay despite having lost their serine protease activity.
    Guillem F; Kannengiesser C; Oudin C; Lenoir A; Matak P; Donadieu J; Isidor B; Méchinaud F; Aguilar-Martinez P; Beaumont C; Vaulont S; Grandchamp B; Nicolas G
    Hum Mutat; 2012 Sep; 33(9):1388-96. PubMed ID: 22581667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The optimal activity of a pseudozymogen form of recombinant matriptase under the mildly acidic pH and low ionic strength conditions.
    Inouye K; Yasumoto M; Tsuzuki S; Mochida S; Fushiki T
    J Biochem; 2010 Apr; 147(4):485-92. PubMed ID: 19919953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for the occurrence of membrane-type serine protease 1/matriptase on the basolateral sides of enterocytes.
    Tsuzuki S; Murai N; Miyake Y; Inouye K; Hirayasu H; Iwanaga T; Fushiki T
    Biochem J; 2005 Jun; 388(Pt 2):679-87. PubMed ID: 15669920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro inhibition of matriptase prevents invasive growth of cell lines of prostate and colon carcinoma.
    Förbs D; Thiel S; Stella MC; Stürzebecher A; Schweinitz A; Steinmetzer T; Stürzebecher J; Uhland K
    Int J Oncol; 2005 Oct; 27(4):1061-70. PubMed ID: 16142324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic upregulation of matriptase-2 reduces the aggressiveness of prostate cancer cells in vitro and in vivo and affects FAK and paxillin localisation.
    Sanders AJ; Parr C; Martin TA; Lane J; Mason MD; Jiang WG
    J Cell Physiol; 2008 Sep; 216(3):780-9. PubMed ID: 18449907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substrate specificity of human matriptase-2.
    Wysocka M; Gruba N; Miecznikowska A; Popow-Stellmaszyk J; Gütschow M; Stirnberg M; Furtmann N; Bajorath J; Lesner A; Rolka K
    Biochimie; 2014 Feb; 97():121-7. PubMed ID: 24161741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addition of beta1-6 GlcNAc branching to the oligosaccharide attached to Asn 772 in the serine protease domain of matriptase plays a pivotal role in its stability and resistance against trypsin.
    Ihara S; Miyoshi E; Nakahara S; Sakiyama H; Ihara H; Akinaga A; Honke K; Dickson RB; Lin CY; Taniguchi N
    Glycobiology; 2004 Feb; 14(2):139-46. PubMed ID: 14551220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.